| Dr David Baumgartner, MD | |
|
1026 A Ave Ne, Eciac, Cedar Rapids, IA 52402-5036 | |
| (319) 369-7451 | |
| (319) 369-7419 |
| Full Name | Dr David Baumgartner |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1026 A Ave Ne, Cedar Rapids, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114364429 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD-42661 (Iowa) | Primary |
| Entity Name | Trinity Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073594156 PECOS PAC ID: 7315858529 Enrollment ID: O20031204000921 |
News Archive
Researchers have identified the link between socioeconomic status and common symptoms of disease, prompting new questions about the causal connections between them.
Manhattan Pharmaceuticals, Inc. announced today that it has been awarded $244,279 in funding under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) credit program. The Company has received this funding for its lead product candidate AST-726 for the treatment of vitamin B12 deficiency.
Data from a new study show that patients with Hepatitis C virus (HCV) taking direct-acting antiviral treatments (DAAs), who have previously fought off hepatocellular carcinoma (HCC), the most common form of liver cancer,1 had a 'high rate' of re-developing their illness.
In 2010, the European Respiratory Society appealed to physicians to "recognize that air pollution is the largest environmental challenge for European citizens, one that currently limits the fundamental right of all individuals to breathe clean air. This challenge is associated with large health effects – effects that will continue to menace public health in the future".
› Verified 6 days ago
| Entity Name | Allen Memorial Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891772927 PECOS PAC ID: 4284546045 Enrollment ID: O20031211000480 |
News Archive
Researchers have identified the link between socioeconomic status and common symptoms of disease, prompting new questions about the causal connections between them.
Manhattan Pharmaceuticals, Inc. announced today that it has been awarded $244,279 in funding under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) credit program. The Company has received this funding for its lead product candidate AST-726 for the treatment of vitamin B12 deficiency.
Data from a new study show that patients with Hepatitis C virus (HCV) taking direct-acting antiviral treatments (DAAs), who have previously fought off hepatocellular carcinoma (HCC), the most common form of liver cancer,1 had a 'high rate' of re-developing their illness.
In 2010, the European Respiratory Society appealed to physicians to "recognize that air pollution is the largest environmental challenge for European citizens, one that currently limits the fundamental right of all individuals to breathe clean air. This challenge is associated with large health effects – effects that will continue to menace public health in the future".
› Verified 6 days ago
| Entity Name | St Lukes Jones Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942397328 PECOS PAC ID: 4688572811 Enrollment ID: O20031226000198 |
News Archive
Researchers have identified the link between socioeconomic status and common symptoms of disease, prompting new questions about the causal connections between them.
Manhattan Pharmaceuticals, Inc. announced today that it has been awarded $244,279 in funding under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) credit program. The Company has received this funding for its lead product candidate AST-726 for the treatment of vitamin B12 deficiency.
Data from a new study show that patients with Hepatitis C virus (HCV) taking direct-acting antiviral treatments (DAAs), who have previously fought off hepatocellular carcinoma (HCC), the most common form of liver cancer,1 had a 'high rate' of re-developing their illness.
In 2010, the European Respiratory Society appealed to physicians to "recognize that air pollution is the largest environmental challenge for European citizens, one that currently limits the fundamental right of all individuals to breathe clean air. This challenge is associated with large health effects – effects that will continue to menace public health in the future".
› Verified 6 days ago
| Entity Name | Grinnell Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669420501 PECOS PAC ID: 0446153662 Enrollment ID: O20040127001219 |
News Archive
Researchers have identified the link between socioeconomic status and common symptoms of disease, prompting new questions about the causal connections between them.
Manhattan Pharmaceuticals, Inc. announced today that it has been awarded $244,279 in funding under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) credit program. The Company has received this funding for its lead product candidate AST-726 for the treatment of vitamin B12 deficiency.
Data from a new study show that patients with Hepatitis C virus (HCV) taking direct-acting antiviral treatments (DAAs), who have previously fought off hepatocellular carcinoma (HCC), the most common form of liver cancer,1 had a 'high rate' of re-developing their illness.
In 2010, the European Respiratory Society appealed to physicians to "recognize that air pollution is the largest environmental challenge for European citizens, one that currently limits the fundamental right of all individuals to breathe clean air. This challenge is associated with large health effects – effects that will continue to menace public health in the future".
› Verified 6 days ago
| Entity Name | New Century Physicians Of Iowa Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548269301 PECOS PAC ID: 4880587070 Enrollment ID: O20040203000297 |
News Archive
Researchers have identified the link between socioeconomic status and common symptoms of disease, prompting new questions about the causal connections between them.
Manhattan Pharmaceuticals, Inc. announced today that it has been awarded $244,279 in funding under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) credit program. The Company has received this funding for its lead product candidate AST-726 for the treatment of vitamin B12 deficiency.
Data from a new study show that patients with Hepatitis C virus (HCV) taking direct-acting antiviral treatments (DAAs), who have previously fought off hepatocellular carcinoma (HCC), the most common form of liver cancer,1 had a 'high rate' of re-developing their illness.
In 2010, the European Respiratory Society appealed to physicians to "recognize that air pollution is the largest environmental challenge for European citizens, one that currently limits the fundamental right of all individuals to breathe clean air. This challenge is associated with large health effects – effects that will continue to menace public health in the future".
› Verified 6 days ago
| Entity Name | Grundy County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114012085 PECOS PAC ID: 6406766435 Enrollment ID: O20040217000174 |
News Archive
Researchers have identified the link between socioeconomic status and common symptoms of disease, prompting new questions about the causal connections between them.
Manhattan Pharmaceuticals, Inc. announced today that it has been awarded $244,279 in funding under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) credit program. The Company has received this funding for its lead product candidate AST-726 for the treatment of vitamin B12 deficiency.
Data from a new study show that patients with Hepatitis C virus (HCV) taking direct-acting antiviral treatments (DAAs), who have previously fought off hepatocellular carcinoma (HCC), the most common form of liver cancer,1 had a 'high rate' of re-developing their illness.
In 2010, the European Respiratory Society appealed to physicians to "recognize that air pollution is the largest environmental challenge for European citizens, one that currently limits the fundamental right of all individuals to breathe clean air. This challenge is associated with large health effects – effects that will continue to menace public health in the future".
› Verified 6 days ago
| Entity Name | Informed Choice Of Iowa Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871043570 PECOS PAC ID: 0345590600 Enrollment ID: O20180906002472 |
News Archive
Researchers have identified the link between socioeconomic status and common symptoms of disease, prompting new questions about the causal connections between them.
Manhattan Pharmaceuticals, Inc. announced today that it has been awarded $244,279 in funding under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) credit program. The Company has received this funding for its lead product candidate AST-726 for the treatment of vitamin B12 deficiency.
Data from a new study show that patients with Hepatitis C virus (HCV) taking direct-acting antiviral treatments (DAAs), who have previously fought off hepatocellular carcinoma (HCC), the most common form of liver cancer,1 had a 'high rate' of re-developing their illness.
In 2010, the European Respiratory Society appealed to physicians to "recognize that air pollution is the largest environmental challenge for European citizens, one that currently limits the fundamental right of all individuals to breathe clean air. This challenge is associated with large health effects – effects that will continue to menace public health in the future".
› Verified 6 days ago
| Entity Name | Emergency Services Of Iowa Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477017663 PECOS PAC ID: 1557600756 Enrollment ID: O20190306001336 |
News Archive
Researchers have identified the link between socioeconomic status and common symptoms of disease, prompting new questions about the causal connections between them.
Manhattan Pharmaceuticals, Inc. announced today that it has been awarded $244,279 in funding under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) credit program. The Company has received this funding for its lead product candidate AST-726 for the treatment of vitamin B12 deficiency.
Data from a new study show that patients with Hepatitis C virus (HCV) taking direct-acting antiviral treatments (DAAs), who have previously fought off hepatocellular carcinoma (HCC), the most common form of liver cancer,1 had a 'high rate' of re-developing their illness.
In 2010, the European Respiratory Society appealed to physicians to "recognize that air pollution is the largest environmental challenge for European citizens, one that currently limits the fundamental right of all individuals to breathe clean air. This challenge is associated with large health effects – effects that will continue to menace public health in the future".
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Baumgartner, MD 1026 A Ave Ne, Eciac, Cedar Rapids, IA 52402-5036 Ph: (319) 369-7451 | Dr David Baumgartner, MD 1026 A Ave Ne, Eciac, Cedar Rapids, IA 52402-5036 Ph: (319) 369-7451 |
News Archive
Researchers have identified the link between socioeconomic status and common symptoms of disease, prompting new questions about the causal connections between them.
Manhattan Pharmaceuticals, Inc. announced today that it has been awarded $244,279 in funding under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) credit program. The Company has received this funding for its lead product candidate AST-726 for the treatment of vitamin B12 deficiency.
Data from a new study show that patients with Hepatitis C virus (HCV) taking direct-acting antiviral treatments (DAAs), who have previously fought off hepatocellular carcinoma (HCC), the most common form of liver cancer,1 had a 'high rate' of re-developing their illness.
In 2010, the European Respiratory Society appealed to physicians to "recognize that air pollution is the largest environmental challenge for European citizens, one that currently limits the fundamental right of all individuals to breathe clean air. This challenge is associated with large health effects – effects that will continue to menace public health in the future".
› Verified 6 days ago
Julie M Beard, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1026 A Avenue, Cedar Rapids, IA 52402 Phone: 319-369-7105 | |
Kathryn K Dierks, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1026 A Ave Ne, Cedar Rapids, IA 52402 Phone: 319-369-8600 | |
Thomas Joseph Ryan Iv, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 701 10th St Se, Cedar Rapids, IA 52403 Phone: 319-398-6037 | |
Bradford Wisnousky, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 10th St Se, Cedar Rapids, IA 52403 Phone: 319-398-6297 Fax: 319-398-6249 | |
Donald J Linder, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1026 A Ave Ne, Cedar Rapids, IA 52402 Phone: 319-369-7105 | |
Catherine Knight, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 10th St Se, Cedar Rapids, IA 52403 Phone: 319-398-6297 |